Literature DB >> 21607613

Safety and efficacy of contraception--Why should the obese woman be any different?

Maria I Rodriguez1, Alison B Edelman.   

Abstract

The public health impact of obesity and unintended pregnancy is profound with far reaching consequences. Obese women are less likely to use contraception due to a variety of self-induced and systems-based barriers but their risk of becoming pregnant is similar to their normal weight counterparts. However, pregnancy-associated risks for obese women are higher than that of normal weight women and thus, pregnancy generally outweighs the risks of contraceptive use. Adequate counselling to prevent and/or plan for pregnancy is imperative for these women. Research that investigates the relationship between obesity and contraceptive use is urgently needed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21607613     DOI: 10.1007/s11154-011-9181-5

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  51 in total

1.  Hormonal contraception: noncontraceptive benefits and medical contraindications.

Authors:  Kristin M Rager; Hatim A Omar
Journal:  Adolesc Med Clin       Date:  2005-10

2.  Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women.

Authors:  Carolyn L Westhoff; Anupama H Torgal; Elizabeth R Mayeda; Malcolm C Pike; Frank Z Stanczyk
Journal:  Contraception       Date:  2010-02-20       Impact factor: 3.375

Review 3.  Hormonal contraceptives for contraception in overweight or obese women.

Authors:  Laureen M Lopez; David A Grimes; Mario Chen-Mok; Carolyn Westhoff; Alison Edelman; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

Review 4.  Obesity in pregnancy.

Authors:  Gregory A L Davies; Cynthia Maxwell; Lynne McLeod
Journal:  J Obstet Gynaecol Can       Date:  2010-02

Review 5.  Disparities in family planning.

Authors:  Christine Dehlendorf; Maria Isabel Rodriguez; Kira Levy; Sonya Borrero; Jody Steinauer
Journal:  Am J Obstet Gynecol       Date:  2010-03       Impact factor: 8.661

Review 6.  Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review.

Authors:  Alison B Edelman; Ganesh Cherala; Frank Z Stanczyk
Journal:  Contraception       Date:  2010-05-26       Impact factor: 3.375

7.  U S. Medical Eligibility Criteria for Contraceptive Use, 2010.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2010-06-18

8.  Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus.

Authors:  Charlotte M Boney; Anila Verma; Richard Tucker; Betty R Vohr
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

9.  Contraceptive efficacy and safety of DMPA-SC.

Authors:  J Jain; A J Jakimiuk; F R Bode; D Ross; A M Kaunitz
Journal:  Contraception       Date:  2004-10       Impact factor: 3.375

10.  Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys.

Authors:  T B Clarkson; C A Shively; T M Morgan; D R Koritnik; M R Adams; J R Kaplan
Journal:  Obstet Gynecol       Date:  1990-02       Impact factor: 7.661

View more
  2 in total

Review 1.  Contraception and the obese woman.

Authors:  Elizabeth Reifsnider; Nonie Mendias; Yolanda Davila; Jennie Bever Babendure
Journal:  J Am Assoc Nurse Pract       Date:  2013-02-27       Impact factor: 1.165

2.  Class III obesity and unwanted pregnancy among women with live births in New York City, 2004-2007.

Authors:  Samantha Garbers; Mary Ann Chiasson
Journal:  Matern Child Health J       Date:  2013-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.